AU2002310922A1 - Interferons in the treatment of ischemia - Google Patents

Interferons in the treatment of ischemia

Info

Publication number
AU2002310922A1
AU2002310922A1 AU2002310922A AU2002310922A AU2002310922A1 AU 2002310922 A1 AU2002310922 A1 AU 2002310922A1 AU 2002310922 A AU2002310922 A AU 2002310922A AU 2002310922 A AU2002310922 A AU 2002310922A AU 2002310922 A1 AU2002310922 A1 AU 2002310922A1
Authority
AU
Australia
Prior art keywords
interferons
ischemia
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002310922A
Inventor
Hubertus Schellekens
Yin Hwee Tan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute of Molecular and Cell Biology
Original Assignee
Institute of Molecular and Cell Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0111070A external-priority patent/GB0111070D0/en
Priority claimed from GB0118023A external-priority patent/GB0118023D0/en
Application filed by Institute of Molecular and Cell Biology filed Critical Institute of Molecular and Cell Biology
Publication of AU2002310922A1 publication Critical patent/AU2002310922A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/215IFN-beta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002310922A 2001-05-04 2002-04-04 Interferons in the treatment of ischemia Abandoned AU2002310922A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0111070.9 2001-05-04
GB0111070A GB0111070D0 (en) 2001-05-04 2001-05-04 Treatment of cerebral ischemia
GB0118023A GB0118023D0 (en) 2001-07-24 2001-07-24 Treatment of ischemia
GB0118023.1 2001-07-24
PCT/EP2002/003758 WO2002089828A2 (en) 2001-05-04 2002-04-04 Interferons in the treatment of ischemia

Publications (1)

Publication Number Publication Date
AU2002310922A1 true AU2002310922A1 (en) 2002-11-18

Family

ID=26246039

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002310922A Abandoned AU2002310922A1 (en) 2001-05-04 2002-04-04 Interferons in the treatment of ischemia

Country Status (2)

Country Link
AU (1) AU2002310922A1 (en)
WO (1) WO2002089828A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2477577A1 (en) * 2002-03-12 2003-09-18 Maxygen Aps Interferon beta-like molecules for treatment of stroke
EP1608400B1 (en) 2003-03-28 2010-06-23 Faron Pharmaceuticals OY Elevation of adenosine level by cytokine-induced expression of cd73
US7348004B2 (en) 2003-05-06 2008-03-25 Syntonix Pharmaceuticals, Inc. Immunoglobulin chimeric monomer-dimer hybrids
TWI353991B (en) 2003-05-06 2011-12-11 Syntonix Pharmaceuticals Inc Immunoglobulin chimeric monomer-dimer hybrids
EP3552627A1 (en) 2003-05-06 2019-10-16 Bioverativ Therapeutics Inc. Clotting factor-fc chimeric proteins to treat hemophilia
FI20051003A0 (en) * 2005-10-07 2005-10-07 Faron Pharmaceuticals Oy A method of treating or preventing an ischemic reperfusion injury or multiple organ disorder

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE462364B (en) * 1988-09-30 1990-06-18 Goeran Hansson USING GAMMA INTERFERON FOR PREPARING A PREPARATION FOR TREATMENT OF VASCULAR STENOS
US5370870A (en) * 1989-10-06 1994-12-06 Genentech, Inc. Method for protection against reactive oxygen species
GB9506051D0 (en) * 1995-03-24 1995-05-10 Univ Singapore Gene expression
WO1997018831A1 (en) * 1995-11-17 1997-05-29 Toray Industries, Inc. Endothelial cell protective
JPH09151137A (en) * 1995-12-01 1997-06-10 Toray Ind Inc Medicine for inhibiting multiplication of smooth muscle cell
ES2314786T3 (en) * 1998-04-02 2009-03-16 Genentech, Inc. USE OF INTERFERON GAMMA FOR THE TREATMENT OF CARDIAC HYPERTROPHY.

Also Published As

Publication number Publication date
WO2002089828A2 (en) 2002-11-14
WO2002089828A3 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
EP1370249A4 (en) Novel dendriticpolymers and their biomedical uses
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
AU2001234837A1 (en) Azapeptides useful in the treatment of hepatitis c
AU2003212634A1 (en) Compounds useful in the treatment of cancer
AU2001260834A1 (en) The treatment of herpes
AU2002319286A1 (en) Skin treatment
GB2376928B (en) Personal hoverplane having four tiltmotors
AU2002310922A1 (en) Interferons in the treatment of ischemia
AU2003220026A1 (en) Methods and compositions for the treatment of ischemia
AU2002312373A1 (en) Structural and cytoskeleton-associated proteins
AU2003293500A1 (en) Lactoferrin in the reduction of pain
AU2002366195A1 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU2001258675A1 (en) Treating infections
AU2002241162A1 (en) Intimins in the prevention or treatment of infections:ii
AU2002365256A1 (en) Gemcitabine in the treatment of smallpox
AU2002316943A1 (en) Hair treatment composition
AU2002343516A1 (en) Structural and cytoskeleton-associated proteins
AU2002320621A1 (en) Structural and cytoskeleton-associated proteins
AU2002229979A1 (en) Polymorphisms in the human cmoat gene and uses thereof
AU2002357468A1 (en) Use of 2-acylindoles in the treatment of tumors
AU2002304728A1 (en) Enzymes combination coadjuvating in the interferon therapy
AU2002310606A1 (en) Surface treatment
AUPR589401A0 (en) Particle treatment
AUPR278101A0 (en) Personal object
AU2002308074A1 (en) Skin treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase